drugset / Trial / NCT06638905
Efficacy and Safety of Skincare Serum and Cream for Anti-aging of Facial Skin
Phase 2/3
Not yet recruiting
18 enrolled
Goldman, Butterwick, Fitzpatrick and Groff
Babor Americas · collab
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of this study is to assess the efficacy and safety of combination therapy of BABOR® Ultimate ECM Repair Serum and the BABOR® Cure Cream for the improvement of anti-aging through the use of investigator assessments, subject questionnaires/assessments, photography, skin imaging, and reported adverse reactions.
Timeline
- Start
- 2024-10-28
- Primary completion
- 2025-03-05
- Completion
- 2025-05-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Babor Cure Cream | Unknown | — | — |
| Subject | Babor Ultimate ECM Repair Serum | Unknown | — | — |